Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60

Oncology

Volumn 57, Issue SUPPL. 2, 1999, Pages 17-25

  Hirase, Nobuhisa ^a   Yanase, Toshihiko ^a   Mu, Yi Ming ^a   Muta, Koichiro ^a   Umemura, Tsukuru ^a   Takayanagi, Ryoichi ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Differentiation; HL60; PPAR ; Thiazolidinedione

Indexed keywords

6 [1 (5,6,7,8 TETRAHYDRO 3,5,5,8,8 PENTAMETHYL 2 NAPHTHYL)CYCLOPROPYL]NICOTINIC ACID; PIOGLITAZONE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; MONOCYTE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

EID: 0032696319     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055271     Document Type: Conference Paper

References (36)

1. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type ?diabetes. Diabetes 1996;45:1661-1669.
2. Spiegelman BM: PPARγ: Adipogenic regulator and thiazolidinedione receptor. Diabetes 1998; 47:507-514.
3. Lehmann JM, Moore LB, Smith-Oliver D, Wilkinson WM, Wilson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 1995;270: 12953-12956.
4. Wilson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM: The structure-activity relationship between peroxisome-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 1996;39:665-668.
5. Tontonoz P, Hu E, Spiegelman BM: Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994;79:1147-1156.
6. Fajas L, Auboeu D, Raspe E, Schoonjans K, Lefebvre A-M, Saladin R, Najib J, Laville M, Fruchart J-C, Deeb S, Vidal-Puig A, Flier J, Briggs MR, Staels B, Vidal H, Auwerx J: The organization, promoter analysis, and expression of the human PPARγ gene. J Biol Chem 1997;272:18779-18789.
7. Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology 1996;137:354-366.
8. Greene ME, Blumberg B, Mcbride OW, Yi HF, Kronquist K, Kwan K, Hsieh L, Greene G, Nimer D: Isolation of the human peroxisome proliferator activated receptor gamma cDNA: Expression in hematopoietic cells and chromosomal mapping. Gene Expr 1995;4:281-299.
9. Gimble JM, Robinson CE, Wu X, Kelly KA, Rodriguez BR, Kliewer SA, Lehmann JM, Morris DC: Peroxisome proliferator-activated receptor-activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol 1996;50:1087-1094.
10. Kosaka K, Kuzuya T, Akanuma H, Shigeta Y, Kaneko T: Clinical evaluation of a new oral hypoglycemic drug Cs-045 in patients with non-insulin dependent diabetes mellitus poorly controlled by sulfonylureas. A double-blind, placebo-controlled study. Rinsho Igaku 1993; 9(suppl):19-37.
11. Collins SJ, Gallo RC, Gallagher RE: Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature 1977;70:1233-1244.
12. Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL60) by retinoic acid. Proc Natl Acad Sci USA 1980;77:2936-2940.
13. McCarthy JV, Fernandes RS, Gotter TG: Increased resistance to apoptosis associated with HL60 myeloid differentiation status. Anticancer Res 1994;14:2063-2072.
14. Benito A, Grillot D, Nunez G, Fernandez-Luna JL: Regulation and function of BCL-2 during differentiation-induced cell death in HL60 promyelocytic cells. Am J Pathol 1995;146:481-490.
15. Watson RWG, Rotstein OD, Parodo J, Bitar R, Hackam D, Marshall JC: Granulocytic differentiation of HL60 cells results in spontaneous apoptosis mediated by increased caspase expression. FFBS Lett 1997;412:603-609.
16. Rovera G, O'Brien TG, Diamond L: Induction of differentiation in human promyelocytic leukemia cells by tumor promoters. Science 1979; 204:868-870.
17. Boehm MF, Zhang L, Zhi L, McClurg MR, Berger E, Wagoner M, Mais DE, Suto CM, Davies PJA, Heyman RA, Nadzan AM: Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem 1995;38:3146-3155.
18. Kinsham A: Rapid flow cytofluorometric analysis of mammallian cell cycle by propidium iodide staining. J Cell Biol 1975;66:188-193.
19. Darzynkiewicz Z, Brouno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P, Tragonos F: Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
20. Selins KS, Cohen JJ: Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987;139:3199.
21. Wyllies AH, Kerr JFR, Kurrie AR: Cell death: The significance of apoptosis. Int Rev Cytol 1980;6:251-306.
22. Chatterjee D, Han Z, Mendoza J, Goodglick L, Hendrickson EA, Pantazis P, Wyche JH: Monocytic differentiation of HL60 promyelocytic leukemia cells correlates with the induction of Bcl-XL. Cell Growth Differ 1997;8: 1083-1089.
23. Nilsson A, Farrants AKO, Nesland JM, Finstad HS, Pederson JI: Potentiating effects of clofibric acid on the differentiation of HL60 human promyelocytic leukemia cells induced by retinoids. Eur J Cell Biol 1995;67:379-385.
24. Mukherjee R, Davies PJA, Crombie DL, Bischoff ED, Casario RM, Jow L, Hamann LG, Boehm MF, Mondon CE, Nadzan AM, Paterniti JR Jr, Heyman RA: Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 1997;386:407-410.
25. Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CDM, Brun RP, Mueller E, Altios S, Oppenheim H, Evans RM, Spiegelman BM: Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator activated receptor y and retinoid X receptor. Proc Natl Acad Sci USA 1997;94:237-241.
26. Umemiya H, Kagechika H, Fukasawa H, Kawachi E, Ebisawa M, Hashimoto Y, Eisenmann G, Erb C, Pornon A, Chambon P, Gronemeyer H, Shudo K: Action mechanism of retinoid-synergistic dibenzodiazepines. Biochem Biophys Res Commun 1997;233:121-125.
27. Suzuki S, Kobayashi H, Sekine R, Kumagai M, Mikoshiba M, Mori J, Hara M, Ichikawa K, Hashizume K: 3,5,3'-Triiodo-L-thyronine potentiates all-trans-retinoic acid-induced apoptosis during differentiation of the promyeloleukemic cell HL60. Endocrinology 1997;138: 805-809.
28. Tontonoz P, Nagy L, Alvarez JGA, Thomazy VA, Evans RM: PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998;93:241-252.
29. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 1991; 352:345-347.
30. Clarke AR, Purdie CA, Harrison DF, Morris RG, Bird CC, Hooper ML, Wyllie AH: Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993;362:849-852.
31. Wolf D, Rotter V: Major deletions in the gene coding the p53 tumor antigen cause lack of p53 expression in HL60 cells. Proc Natl Acd Sci USA 1985;82:790-794.
32. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-512.
33. Reed JC: Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt 1996;97:72-100.
34. Sanz C, Benito A, Silva M, Albella B, Richard C, Segovia JC, Insunza A, Buerren JA, Fernandez-Luna JL: The expression of bcl-X is down-regulated during differentiation of human hematopoietic progenitor cells along the granulocyte but not the monocyte/macrophage lineage. Blood 1997;89:3199-3204.
35. Oltval Z, Millman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-619.
36. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ: Bad, a heterodimeric partner for Bcl-XL and Bcl-2 displaces Bax and promotes cell death. Cell 1995;80:285-291.